Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
neurocare Academy is the educational division of the neurocare group, a global leader in personalized mental health and neuromodulation. The Academy provides specialized training and certification for healthcare professionals in evidence-based technologies, including Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), and Neurofeedback. Their programs are designed to bridge the gap between scientific research and clinical application, offering clinicians the tools to implement personalized treatment protocols for disorders such as depression, ADHD, and insomnia. Beyond technical training, the Academy offers ongoing clinical support and access to a global network of experts to ensure high standards of patient care. By integrating hardware, software, and specialized knowledge, neurocare Academy facilitates the adoption of non-invasive brain stimulation techniques in psychiatric and neurological practices worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on neurocare Academy.